Impedimed Limited Stock Analysis

IPDQF Stock  USD 0.08  0  5.43%   
ImpediMed Limited is overvalued with Real Value of 0.0623 and Hype Value of 0.08. The main objective of ImpediMed pink sheet analysis is to determine its intrinsic value, which is an estimate of what ImpediMed Limited is worth, separate from its market price. There are two main types of ImpediMed's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect ImpediMed's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of ImpediMed's stock to identify patterns and trends that may indicate its future price movements.
The ImpediMed pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. ImpediMed is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. ImpediMed Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ImpediMed's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImpediMed Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

ImpediMed Pink Sheet Analysis Notes

About 14.0% of the company shares are held by company insiders. The book value of ImpediMed was currently reported as 0.03. The company recorded a loss per share of 0.01. ImpediMed Limited had not issued any dividends in recent years. The entity had 1027:1000 split on the 17th of November 2014. ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy devices and software services in Australia, North America, and internationally. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia. Impedined operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 73 people.The quote for ImpediMed Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about ImpediMed Limited call Richard Carreon at 61 7 3860 3700 or check out https://www.impedimed.com.

ImpediMed Limited Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ImpediMed's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ImpediMed Limited or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ImpediMed Limited is way too risky over 90 days horizon
ImpediMed Limited has some characteristics of a very speculative penny stock
ImpediMed Limited appears to be risky and price may revert if volatility continues
The company reported the revenue of 10.49 M. Net Loss for the year was (19.87 M) with profit before overhead, payroll, taxes, and interest of 9.16 M.
ImpediMed Limited has accumulated about 40.73 M in cash with (15.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 14.0% of the company shares are held by company insiders

ImpediMed Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 78.57 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ImpediMed's market, we take the total number of its shares issued and multiply it by ImpediMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

ImpediMed Profitablity

ImpediMed's profitability indicators refer to fundamental financial ratios that showcase ImpediMed's ability to generate income relative to its revenue or operating costs. If, let's say, ImpediMed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, ImpediMed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of ImpediMed's profitability requires more research than a typical breakdown of ImpediMed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.88) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.0) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.0.

Technical Drivers

As of the 19th of April, ImpediMed retains the Market Risk Adjusted Performance of (0.07), downside deviation of 27.56, and Risk Adjusted Performance of 0.0328. ImpediMed technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to break down and collect data for nineteen technical drivers for ImpediMed Limited, which can be compared to its competitors. Please check out ImpediMed Limited treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if ImpediMed is priced fairly, providing market reflects its last-minute price of 0.0815 per share. As ImpediMed Limited appears to be a penny stock we also urge to confirm its total risk alpha numbers.

ImpediMed Limited Price Movement Analysis

Execute Study
null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ImpediMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ImpediMed Limited. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

ImpediMed Predictive Daily Indicators

ImpediMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ImpediMed pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

ImpediMed Forecast Models

ImpediMed's time-series forecasting models are one of many ImpediMed's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ImpediMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About ImpediMed Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how ImpediMed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ImpediMed shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as ImpediMed. By using and applying ImpediMed Pink Sheet analysis, traders can create a robust methodology for identifying ImpediMed entry and exit points for their positions.
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy devices and software services in Australia, North America, and internationally. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia. Impedined operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 73 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding ImpediMed to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImpediMed Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for ImpediMed Pink Sheet analysis

When running ImpediMed's price analysis, check to measure ImpediMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImpediMed is operating at the current time. Most of ImpediMed's value examination focuses on studying past and present price action to predict the probability of ImpediMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImpediMed's price. Additionally, you may evaluate how the addition of ImpediMed to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Please note, there is a significant difference between ImpediMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImpediMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImpediMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.